LCN2 and congenital heart disease: In a randomized controlled trial, Ricci et al. showed that fenoldopam infusion in children with congenital heart disease who were undergoing cardiopulmonary bypass decreased the levels of urinary cystatin C and NGAL at the end of surgery and at 12 h after surgery [34].